Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term effects of Aldara 5% cream vs Solaraze in actinic keratosis
2010-022054-16Phase 4Completed
- Sponsor
- Meda
- Start
- May 2011
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of imiquimod and diclofenac in actinic keratosis (AK) (2 arms), sponsored by Meda. Primary endpoint: Histologic progression to squamous cell carcinoma. Started May 2011; status: completed.
02
Drugs
imiquimoddiclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2010-022054-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022054-16.